Valeant Acquires Obagi, Which Biotechs Are Next?
Yesterday, Obagi Medical Products (OMPI) was acquired by Valeant Pharmaceuticals (VRX) for $19.75 a share in an all cash deal. Last summer I covered in depth, acquisition rumors regarding Obagi. At the...
View Article4 Top Small Cap Biotech Acquisition Targets
Today, I list small cap companies I believe are top acquisition targets for large pharma. I combine speculation, rumors and buzz I am hearing, and company financial position as a few factors for...
View ArticleVideo: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included. The post Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary appeared...
View ArticleTrius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer...
View ArticleVoce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David...
Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market. Sometimes both activist institutions and private investors can leverage deals or stop deals...
View ArticleEdited: Is An Acquisition Of Solta Medical Imminent?
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments....
View ArticleImportant Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson...
View ArticleThe Biotech Merger And Acquisition Buzz List
Merger and acquisition rumors are heard on a daily basis throughout the market. Some have merit and turn out to be true, while others turn out to be false and without merit. Today, I will cover some...
View ArticleVideo: (Updated) My Solta-Zeltiq Merger Thesis (Public Free Video)
Hi guys, Scott here with ya! Because so many people are asking me about $SLTM and what I believe is going on with them, I have made a public video for you to listen to my thesis regarding this matter....
View ArticleFairway Group Likely To Beat On Bottom Line EPS – Strong Acquisition Candidate
Summary On May 28th, 2015, Fairway is scheduled to report its earnings from its last quarter. During the last quarter, the EURO dollar weakened substantially while the dollar gained. This factor has...
View ArticleBiotech and StockMarket Podcast May 31 2016
Biotech and StockMarket Podcast May 31 2016... $IONS $RLYP Gold, Oil + Macros $IONs discussed here on why we took call options. Danny explains the situation there and why it's not as bad as the market...
View Article4 Top Small Cap Biotech Acquisition Targets
Today, I list small cap companies I believe are top acquisition targets for large pharma. I combine speculation, rumors and buzz I am hearing, and company financial position as a few factors for...
View ArticleVideo: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included. The post Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary appeared...
View ArticleTrius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer...
View ArticleVoce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David...
Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market. Sometimes both activist institutions and private investors can leverage deals or stop deals...
View ArticleEdited: Is An Acquisition Of Solta Medical Imminent?
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments....
View ArticleImportant Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson...
View ArticleThe Biotech Merger And Acquisition Buzz List
Merger and acquisition rumors are heard on a daily basis throughout the market. Some have merit and turn out to be true, while others turn out to be false and without merit. Today, I will cover some...
View ArticleVideo: (Updated) My Solta-Zeltiq Merger Thesis (Public Free Video)
Hi guys, Scott here with ya! Because so many people are asking me about $SLTM and what I believe is going on with them, I have made a public video for you to listen to my thesis regarding this matter....
View ArticleFairway Group Likely To Beat On Bottom Line EPS – Strong Acquisition Candidate
Summary On May 28th, 2015, Fairway is scheduled to report its earnings from its last quarter. During the last quarter, the EURO dollar weakened substantially while the dollar gained. This factor has...
View Article
More Pages to Explore .....